Cooper Companies (NASDAQ:COO) Updates FY25 Earnings Guidance

Cooper Companies (NASDAQ:COO) updated its FY25 earnings guidance on Thursday. The company provided EPS guidance of $3.92-$4.02 for the period, compared to the consensus EPS estimate of $4.06. The company issued revenue guidance of $4.080-$4.158 billion, compared to the consensus revenue estimate of $4.19 billion. Cooper Companies also updated its FY 2025 guidance to 3.920-4.020 EPS.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on COO. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday. Piper Sandler boosted their target price on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. StockNews.com raised Cooper Companies from a “hold” rating to a “buy” rating in a research note on Tuesday. Stifel Nicolaus reiterated a “buy” rating and issued a $115.00 price objective (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Finally, Wells Fargo & Company boosted their price objective on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Trading Down 1.7 %

Shares of NASDAQ:COO opened at $103.23 on Friday. The firm has a market cap of $20.56 billion, a price-to-earnings ratio of 57.35, a PEG ratio of 2.24 and a beta of 0.97. Cooper Companies has a 12 month low of $82.69 and a 12 month high of $112.38. The company’s fifty day simple moving average is $104.72 and its 200 day simple moving average is $98.77. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the prior year, the firm earned $0.87 earnings per share. Cooper Companies’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, research analysts forecast that Cooper Companies will post 3.65 EPS for the current fiscal year.

Insider Transactions at Cooper Companies

In related news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the transaction, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. This represents a 41.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Agostino Ricupati sold 1,601 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the transaction, the chief accounting officer now directly owns 4,818 shares in the company, valued at $520,488.54. This trade represents a 24.94 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.00% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.